I thought the quarterly read well, its a summary of events.
Considering there were no RACs signed up at the start of November, collecting two in what is arguably the quietest time of the year is a promising start.
There is plenty of cash in the bank to get through this period.
This quarter PainChek will need to start putting pen to paper with a few companies to have this rerate on. Until then traders and no idea investors will play around with this stock.
PCK Price at posting:
6.2¢ Sentiment: Buy Disclosure: Held
